⌘K

Login Start Free

Home/Filings/6-K/0001213900-25-121941

6-K//Foreign company update

Clearmind Medicine Inc. 6-K

Accession 0001213900-25-121941

$CMNDCIK 0001892500other

View on SEC.gov Company Profile

Filed

Dec 15, 7:00 PM ET

Accepted

Dec 16, 8:50 AM ET

Size

26.7 KB

Accession

0001213900-25-121941

Documents

3 files

6-K
ea0269845-6k_clearmind.htmPrimary
REPORT OF FOREIGN PRIVATE ISSUER
EX-99.1
ea026984502ex99-1_clearmind.htm
PRESS RELEASE TITLED: "CLEARMIND MEDICINE ANNOUNCES SUCCESSFUL COMPLETION OF SECOND COHORT ENROLLMENT IN ONGOING FDA-APPROVED PHASE I/IIA TRIAL FOR CMND-100"
GRAPHIC
ex99-1_001.jpg
GRAPHIC

Issuer

Clearmind Medicine Inc.

CIK 0001892500

Entity typeother

IncorporatedCanada (Federal Level)

Related Parties

1

filerCIK 0001892500

Filing Metadata

Form type: 6-K
Filed: Dec 15, 7:00 PM ET
Accepted: Dec 16, 8:50 AM ET
Size: 26.7 KB

View on SEC.gov